Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12

Journal of Neurosurgery

Volumn 97, Issue 3, 2002, Pages 611-618

  Yamanaka, Ryuya ^a   Zullo, Susan A ^a   Ramsey, Jay ^a   Yajima, Naoki ^a   Tsuchiya, Naoto ^a   Tanaka, Ryuichi ^a   Blaese, Michael ^a   Xanthopoulos, Kleanthis G ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Brain noeplasm; Dendritic cell; Gene therapy; Interleukin 12; Semliki Forest virus

Indexed keywords

INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; BRAIN TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DENDRITIC CELL; DNA MODIFICATION; GENE THERAPY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SEMLIKI FOREST ALPHAVIRUS; TUMOR MODEL;

EID: 0036713240     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.97.3.0611     Document Type: Article

References (40)

1. Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model
2. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
3. Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor
4. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
5. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
6. Recombinant adenovirustransduced dendritic cell immunization in a murine model of central nervous system tumor
7. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
8. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
9. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors
10. Combined chemokine and cytokine gene transfer enhances antitumor immunity
11. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses
12. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy
13. Interleukin-12
14. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production
15. Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
16. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages
17. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study
18. Promoter for Sindbis virus RNA-dependent subgenomic RNA transcrption
19. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens
20. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
21. The basic science of gene therapy
22. Recombinant IL12 administration induces tumor regression in association with IFN-gamma production
23. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas
24. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12
25. Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms
26. Recombinant Sindbis virus as an expression system for cell biology
27. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
28. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors
29. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo
30. Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion
31. Dendritic cells in the T-cell areas of lymphoid organs
32. The alphaviruses: Gene expression, replication, and evolution
33. Antitumor effects of interleukin-12 (IL-12): Applications for the immunotherapy and gene therapy of cancer
34. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
35. Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells
36. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus
37. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA
38. Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12
39. Cancer therapy using a self-replicating RNA vaccine
40. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines